| abstract |
The present invention provides a transient receptor latent vanilloid (TRPV) modulator of formula (I). In particular, the compounds described herein are useful for the treatment or prevention of diseases, conditions and / or disorders regulated by TRPV3. The present disclosure also provides the compounds described herein, intermediates used in the synthesis of the compounds, methods of preparing their pharmaceutical compositions, and methods of treating or preventing diseases, conditions and / or disorders controlled by TRPV3. |